Il trial REWIND [56] stato uno studio multicentrico, randomizzato, in doppio cieco, controllato con placebo, in cui 9901 pazienti diabetici con precedente evento cardiovascolare o con fattori di rischio cardiovascolare sono stati assegnati casualmente (1:1) a una iniezione sottocutanea settimanale di dulaglutide (1,5 mg) o placebo
The significance of a 6.8 mmHg reduction extends beyond the raw number
Ultimately, the best GLP-1 medication is one that you and your healthcare provider agree will best serve your needs
The theca interna cells in turn protect oocyte during its maturation phase from getting damaged by excess ROS
This may reflect differences across the studies including the duration of illness, age (in particular, the lower mean age of both healthy controls and MDD patients in the studies of occipital cortex), and medication use
Yes, like every other weight loss medication, GLP-1 medications also have temporary side effects